Benefit of mepolizumab for asthma not proven in trials
Monday, May 2, 2016 - 13:10
in Health & Medicine
Stephen FellerWASHINGTON, May 2 (UPI) -- The drug safety agency in Germany has questioned the efficacy of mepolizumab, a drug for severe asthma, after finding clinical trials for its use inadequate.